Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
0.980
+0.020 (2.08%)
At close: Jun 26, 2026, 4:00 PM EDT
1.000
+0.020 (2.04%)
After-hours: Jun 26, 2026, 7:04 PM EDT
Revelation Biosciences Employees
Revelation Biosciences had 9 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
9
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,389,418
Market Cap
3.83M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9 | 0 | - |
| Dec 31, 2024 | 9 | -1 | -10.00% |
| Dec 31, 2023 | 10 | 4 | 66.67% |
| Dec 31, 2022 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| FibroBiologics | 15 |
| Ensysce Biosciences | 10 |
| Artelo Biosciences | 7 |
| Galmed Pharmaceuticals | 6 |
| GRI Bio | 4 |
| CDT Equity | 4 |
| SciSparc | 3 |
REVB News
- 12 days ago - Revelation Biosciences Transcript: Transcript - Transcripts
- 16 days ago - Revelation Biosciences Earnings release - Filings
- 16 days ago - Revelation Biosciences Earnings release - Filings
- 26 days ago - Revelation Biosciences adds two new members to AKI Advisory Board - TheFly
- 27 days ago - Revelation Biosciences Expands Acute Kidney Injury Advisory Board - Accesswire
- 6 weeks ago - Revelation Biosciences reports FY25 EPS ($14.35) vs ($1,052.16) last year - TheFly
- 6 weeks ago - Revelation Biosciences, Inc. Releases Corporate Update Letter to Stockholders - Accesswire
- 7 weeks ago - Revelation Biosciences, Inc. Announces Financial Results For the Three Months Ended March 31, 2026 - Accesswire